Colonic carcinogenesis along different genetic routes: Glycophenotyping of tumor cases separated by microsatellite instability/stability

Histochemistry and Cell Biology

Volumn 138, Issue 2, 2012, Pages 339-350

  Gebert, Johannes ^a   Kloor, Matthias ^a   Lee, Jennifer ^a   Lohr, Michaela ^b   André, Sabine ^b   Wagner, Rudolf ^c   Kopitz, Juergen ^a   Gabius, Hans Joachim ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Westpfalz Klinikum GmbH   (Germany)

Author keywords

Glycoprotein; Lectin; Malignancy; Microsatellite instability; Sialylation

Indexed keywords

AGGLUTININ I; ERYTHROAGGLUTININ; GALECTIN 3; GALECTIN 4; GLYCAN; GLYCOPROTEIN; JACALIN; LECTIN; LEUKOAGGLUTININ; MONOSACCHARIDE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; ARTOCARPUS HETEROPHYLLUS; COLON CARCINOGENESIS; DOLICHOS BIFLORUS; ENZYME LOCALIZATION; GENETIC HETEROGENEITY; GLYCOPHENOTYPING; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMAGING; MAACKIA AMURENSIS; MICROSATELLITE INSTABILITY; PEANUT; PHASEOLUS VULGARIS; PHENOTYPE; PRIORITY JOURNAL; SAMBUCUS NIGRA; SIALYLATION;

CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; GALECTINS; GLYCOSYLATION; HUMANS; MICROSATELLITE INSTABILITY; PHENOTYPE; PLANT LECTINS; POLYSACCHARIDES;

EID: 84867396120     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-012-0957-9     Document Type: Article

References (55)

1. André S, Unverzagt C, Kojima S, Frank M, Seifert J, Fink C, Kayser K, von der Lieth C-W, Gabius H-J (2004) Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNac in silico, in vitro and in vivo. Eur J Biochem 271:118-134
2. André S, Kojima S, Gundel G, Russwurm R, Schratt X, Unverzagt C, Gabius H-J (2006) Branching mode in complex-type triantennary N-glycans as regulatory element of their ligand properties. Biochim Biophys Acta 1760:768-782
3. André S, Sanchez-Ruderisch H, Nakagawa H, Buchholz M, Kopitz J, Forberich P, Kemmner W, Böck C, Deguchi K, Detjen KM, Wiedenmann B, von Knebel-Döberitz M, Gress TM, Nishimura S-I, Rosewicz S, Gabius H-J (2007) Tumor suppressor p16INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 274:3233-3256
4. André S, Kozár T, Kojima S, Unverzagt C, Gabius H-J (2009) From structural to functional glycomics: core substitutions as molecular switches for shape and lectin affinity of N-glycans. Biol Chem 390:557-565
5. Bi S, Baum LG (2009) Sialic acids in T cell development and function. Biochim Biophys Acta 1790:1599-1610
6. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257
7. Boscher C, Dennis JW, Nabi IR (2011) Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol 23:383-392
8. Bresalier RS, Boland CR, Kim YS (1985) Regional differences in normal and cancer-associated glycoconjugates of the human colon. J Natl Cancer Inst 75:249-260
9. Chokhawala HA, Huang S, Lau K, Yu H, Cheng J, Thon V, Hurtado-Ziola N, Guerrero JA, Varki A, Chen X (2008) Combinatorial chemoenzymatic synthesis and high-throughput screening of sialosides. ACS Chem Biol 3:567-756
10. Dall'Olio F, Malagolini N, Di Stefano G, Ciambella M, Serafini-Cessi F (1991) a2, 6-Sialylation of N-acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with nonadherent growth. Int J Cancer 47:291-297
11. El-Bchiri J, Buhard O, Penard-Lacronique V, Thomas G, Hamelin R, Duval A (2005) Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers. Hum Mol Genet 14:2435-2442
12. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
13. Findeisen P, Kloor M, Merx S, Sutter C, Woerner SM, Dostmann N, Benner A, Dondog B, Pawlita M, Dippold W, Wagner R, Gebert J, von Knebel Doeberitz M (2005) T25 repeat in the 30 untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 65:8072-8078
14. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S, Gabius H-J, Khachigian L, Detjen K, Rosewicz S (2005) Galectin-1 interacts with the a5b1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 280:37266-37277
15. Gabius H-J, André S, Jiménez-Barbero J, Romero A, Solís D (2011) From lectin structure to functional glycomics: principles of the sugar code. Trends Biochem Sci 36:298-313
16. Huang MC, Chen HY, Huang HC, Huang J, Liang JT, Shen TL, Lin NY, Ho CC, Cho IM, Hsu SM (2006) C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene 25:3267-3276
17. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561
18. Ionov Y, Nowak N, Perucho M, Markowitz S, Cowell JK (2004) Manipulation of nonsense mediated decay identifies gene mutations in colon cancer cells with microsatellite instability. Oncogene 23:639-645
19. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS (1989) Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 49:197-204
20. Kaltner H, Gabius H-J (2012) A toolbox of lectins for translating the sugar code: the galectin network in phylogenesis and tumors. Histol Histopathol 27:397-416
21. Knibbs RN, Goldstein IJ, Ratcliffe RM, Shibuya N (1991) Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins. J Biol Chem 266:83-88
22. Krzeminski M, Singh T, André S, Lensch M, Wu AM, Bonvin AMJJ, Gabius H-J (2011) Human galectin-3 (Mac-2 antigen): defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region. Biochim Biophys Acta 1810:150-161
23. Lahm H, André S, Höflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius H-J (2001) Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127:375-386
24. Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P, Gabius H-J (2007) Geneexpression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 51:681-690
25. Lawes DA, SenGupta S, Boulos PB (2003) The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 29:201-212
26. Lohr M, Kaltner H, Lensch M, André S, Sinowatz F, Gabius H-J (2008) Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7. Histochem Cell Biol 130:567-581
27. Lohr M, Kaltner H, Schwartz-Albiez R, Sinowatz F, Gabius H-J (2010) Towards functional glycomics by lectin histochemistry: strategic probe selection to monitor core and branch-end substitutions and detection of cell-type and regional selectivity in adult mouse testis and epididymis. Anat Histol Embryol 39:481-493
28. Lundin M, Nordling S, Roberts PJ, Lundin J, Carpelan-Holmstrom M, von Boguslawsky K, Haglund C (1999) Sialyl Tn is a frequently expressed antigen in colorectal cancer: no correlation with patient prognosis. Oncology 57:70-76
29. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338
30. Morelle W, Stechly L, André S, van Seuningen I, Porchet N, Gabius H-J, Michalski JC, Huet G (2009) Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking. Biol Chem 390:529-544
31. Murayama T, Zuber C, Seelentag WK, Li WP, Kemmner W, Heitz PU, Roth J (1997) Colon carcinoma glycoproteins carrying a2, 6-linked sialic acid reactive with Sambucus nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl-Tn antigen. Int J Cancer 70:575-581
32. Nagy N, Legendre H, Engels O, André S, Kaltner H, Wasano K, Zick Y, Pector J-C, Decaestecker C, Gabius H-J, Salmon I, Kiss R (2003) Refined prognostic evaluation in colon cancer using immunohistochemical galectin fingerprinting. Cancer 97:1849-1858
33. Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius H-J, Lotan R (1995) Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 55:2191-2199
34. Patsos G, Corfield A (2009) O-glycosylation: structural diversity and function. In: Gabius H-J (ed) The sugar code. Fundamentals of glycosciences. Wiley-VCH, Weinheim, pp 111-137
35. Patsos G, André S, Roeckel N, Gromes R, Gebert J, Kopitz J, Gabius H-J (2009) Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a genedependent effect on the cell surface glycan profile. Glycobiology 19:726-734
36. Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, Bresalier R, Marcon N, Brenner DE, Lubman DM (2008) Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res 7:1693-1703
37. Roth J (2011) Lectins for histochemical demonstration of glycans. Histochem Cell Biol 136:117-130
38. Royrvik EC, Ahlquist T, Rognes T, Lothe RA (2007) Slip slidin' away: a duodecennial review of targeted genes in mismatch repair deficient colorectal cancer. Crit Rev Oncog 13:229-257
39. Sams JS, Lynch HT, Burt RW, Lanspa SJ, Boland CR (1990) Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer. Cancer 66:502-508
40. Sanchez-Ruderisch H, Fischer C, Detjen KM, Welzel M, Wimmel A, Manning JC, André S, Gabius H-J (2010) Tumor suppressor p16INK4a: downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J 277:3552-3563
41. Sanchez-Ruderisch H, Detjen KM, Welzel M, André S, Fischer C, Gabius H-J, Rosewicz S (2011) Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor a5b1-integrin. Cell Death Differ 18:806-816
42. Sata T, Roth J, Zuber C, Stamm B, Heitz PU (1991) Expression of a2, 6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. Am J Pathol 139:1435-1448
43. Sata T, Roth J, Zuber C, Stamm B, Rinderle SJ, Goldstein IJ, Heitz PU (1992) Studies on the Thomsen-Friedenreich antigen in human colon with the lectin Amaranthin. Normal and neoplastic epithelium express only cryptic T antigen. Lab Invest 66:175-186
44. Saussez S, de Leval L, Decaestecker C, Sirtaine N, Cludts S, Duray A, Chevalier D, André S, Gabius H-J, Remmelink M, Leroy X (2010) Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histol Histopathol 25:541-550
45. Schwartz-Albiez R (2009) Inflammation and glycosciences. In: Gabius H-J (ed) The sugar code. Fundamentals of glycosciences. Wiley-VCH, Weinheim, pp 447-467
46. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL (2005) Hypersialylation of b1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by upregulating cell motility. Cancer Res 65:4645-4652
47. Seelentag WK, Li WP, Schmitz SF, Metzger U, Aeberhard P, Heitz PU, Roth J (1998) Prognostic value of b1, 6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 58:5559-5564
48. Solís D, Maté MJ, Lohr M, Ribeiro JP, López-Merino L, André S, Buzamet E, Cañada FJ, Kaltner H, Lensch M, Ruiz FM, Haroske G, Wollina U, Kloor M, Kopitz J, Sáiz JL, Menéndez M, Jiménez-Barbero J, Romero A, Gabius H-J (2010) N-Domain of human adhesion/growth-regulatory galectin-9: preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution. Int J Biochem Cell Biol 42:1019-1029
49. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816-819
50. van de Wouwer M, André S, Gabius H-J, Villalobo A (2011) Nitric oxide changes distinct aspects of the glycophenotype of human neuroblastoma NB69 cells. Nitric Oxide 24:91-101
51. Vazquez-Martin C, Gil-Martin E, Fernandez-Briera A (2005) Elevation of ST6Gal I activity in malignant and transitional tissue in human colorectal cancer. Oncology 69:436-444
52. Wu AM, Wu JH, Liu J-H, Singh T, André S, Kaltner H, Gabius H-J (2004) Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galb1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 86:317-326
53. Yang JM, Byrd JC, Siddiki BB, Chung YS, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I (1994) Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology 4:873-884
54. Zhuo Y, Bellis SL (2011) Emerging role of α2, 6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem 286:5935-5941
55. Zuber C, Roth J (2009) N-Glycosylation. In: Gabius H-J (ed) The sugar code. Fundamentals of glycosciences. Wiley-VCH, Weinheim, pp 87-110